Witnessing the stock’s movement on the chart, on Wednesday, Gilead Sciences, Inc (NASDAQ: GILD) set off with pace as it heaved 0.70% to $128.07, before settling in for the price of $127.18 at the close. Taking a more long-term approach, GILD posted a 52-week range of $86.08-$127.68.
It was noted that the giant of the Healthcare sector posted annual sales growth of -38.13% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -38.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 76.81%. This publicly-traded company’s shares outstanding now amounts to $1.24 billion, simultaneously with a float of $1.24 billion. The organization now has a market capitalization sitting at $158.89 billion. At the time of writing, stock’s 50-day Moving Average stood at $118.09, while the 200-day Moving Average is $111.69.
Gilead Sciences, Inc (GILD) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – General industry. Gilead Sciences, Inc’s current insider ownership accounts for 0.19%, in contrast to 88.16% institutional ownership. According to the most recent insider trade that took place on Nov 17 ’25, this organization’s Chief Financial Officer sold 2,500 shares at the rate of 125.23, making the entire transaction reach 313,075 in total value, affecting insider ownership by 154,555. Preceding that transaction, on Nov 17 ’25, Company’s Chief Commercial Officer sold 28,000 for 125.86, making the whole transaction’s value amount to 3,524,173. This particular insider is now the holder of 107,193 in total.
Gilead Sciences, Inc (GILD) Earnings and Revenue Records
Gilead Sciences, Inc’s EPS increase for this current 12-month fiscal period is 76.81% and is forecasted to reach 8.69 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 26.25% through the next 5 years, which can be compared against the -38.13% growth it accomplished over the previous five years trading on the market.
Gilead Sciences, Inc (NASDAQ: GILD) Trading Performance Indicators
Let’s observe the current performance indicators for Gilead Sciences, Inc (GILD). It’s Quick Ratio in the last reported quarter now stands at 1.31. Alongside those numbers, its PE Ratio stands at $19.84, and its Beta score is 0.31. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.47. Similarly, its price to free cash flow for trailing twelve months is now 17.34.
In the same vein, GILD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.46, a figure that is expected to reach 1.89 in the next quarter, and analysts are predicting that it will be 8.69 at the market close of one year from today.
Technical Analysis of Gilead Sciences, Inc (GILD)
Going through the that latest performance of [Gilead Sciences, Inc, GILD]. Its last 5-days volume of 7.33 million was inferior to the volume of 7.95 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 86.99% While, its Average True Range was 70.44.
Raw Stochastic average of Gilead Sciences, Inc (GILD) in the period of the previous 100 days is set at 99.85%, which indicates a major rise in contrast to 99.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.74 that was higher than 2.71 volatility it exhibited in the past 100-days period.
